3i 31/3/26 NAV of 3,030pps 2% below JPMe; Action LFL YTD to May-26 2.4% vs JPMe 4.0%; shares down 19% at 36% discount - £750m buyback will be accretive; Overweight

Research evidence excerpt

3i 31/3/26 NAV of 3,030pps 2% below JPMe; Action LFL YTD to May-26 2.4% vs JPMe 4.0%; shares down 19% at 36% discount - £750m buyback will be accretive; Overweight

ose

securities covered by analyst(s) within the relevant J.P. Morgan Cazenove sub-sectors. The J.P. Morgan Cazenove sub-sectors are fund of funds

(multi-manager) and single manager funds.

Research Ratings Distribution:

For investment trust and private equity companies, J.P. Morgan Cazenove research has 157 companies under coverage. 35% have been assigned

an OVERWEIGHT rating. 24% of companies within this rating are investment banking clients of the firm. 48% have been assigned an

NEUTRAL rating. 13% of companies within this rating are investment banking clients of the firm. 17% have been assigned an

UNDERWEIGHT rating. 8% of companies within this rating are investment banking clients of the firm.

Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies,

please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst or your J.P.

Morgan representative, or email research.disclosure.inquiries@jpmorgan.com. For material information about the proprietary models used,

please see the Summary of Financials in company-specific research reports and the Company Tearsheets, which are available to download on

the company pages of our client website, http://www.jpmorganmarkets.com. This report also sets out within it the material underlying

assumptions used.

History of Investment Recommendations:

A history of J.P. Morgan investment recommendations disseminated during the preceding 12 months can be accessed on the Research &